Featured Opinions
Where Have All The R&D Jobs Gone?
by Clifford M
Over the past three years, more than 90,000 pharmaceutical employees [1]have [1] http://www.biojobblog.com/2009/04/articles/biojobbuzz/why-downsizing-may-hurt-pharma/
by Anonymous (not verified)
Sometimes we make things way more complicated than they need to be. That's no surprise really.
FDA expects drug company marketers to be mind readers
=============================================================================
Diffusion of innovation - why your product launch is underperforming
The R&D guys have done a great job and uncovered a revolutionary solution but when innovation meets market, market rejects, why?
Life sciences layoffs beginning to spill over to medical devices companies
by Clifford M
Medtronics, the world's largest medical-device company, announced today that it will lay off 1,500-1,800 employees after posting a fiscal fourth-quarter profit that plunged 69 percent on slipping sale
Pharmacists - adherence superheroes?
by Anonymous (not verified)
An interesting national program in New Zealand aims to change the focus of pharmacists from mainly dispensing services to delivering the clinical skills these healthcare professionals have been trained to have more effectively and appropriately.
Time for a change: BIO studyUS students falling behind in bioscience education
by Clifford M
The Biotechnology Industry Organization (BIO) kicked off its annual meeting in Atlanta, Georgia today and shortly thereafter, issued a press release detailing an education study (that it commissioned)
The tragedy of patient compliance
This post begins an examination of the flawed concept of Patient Compliance, its implications, and possible remedies.
by Anonymous (not verified)
A well-known Vice President at a Top 10 Pharma company recently spoke to me over the phone. See if you agree?
In defense of pharma and patient spokespeople
by WendyB
The /Wall Street Journal/ published a big article on the front page May 14 about a bipolar patient who had been speaking on behalf of BMS, and is now basically speaking out against the company.
Three Steps to Hiring Top Performing Salespeople
by Steven Rosen
In a discussion with the head of sales of a mid-sized pharmaceutical company, he wanted to know why some front-line sales managers are much better than others at hiring top performers.
Pfizer takes the first steps toward establishing trust with a skeptical public
Pfizer Inc announced today that it will launch an innovative program to help eligible unemployed Americans and their families who have lost their health insurance maintain access to their Pfizer medic
Merck & Vioxx.. Will pharma's heart ever be in the right place?
When I stumbled upon a recent Guardian article about the current court case in Australia regarding the link between taking Merck drug Vioxx, and suffering a heart attack, I was not immediately surpris
Is a brand really a brand in pharma?
Big brands, big profits? That is not true anymore just ask the people from Starbucks, Palm, Nissan and GM.
The natural evolution of the Internet for healthcare marketers
There are many people who have been surprised by the "overnight" popularity of social media but I would suggest that this is not a splash in the water but rather an evolution of the Internet and how u
Certified reps an idea whose time has come
by Anonymous (not verified)
Brave New World in emarketing?
by Anonymous (not verified)
With the increasing short- and long-term pressures on pharma and the strategic focus on new business models, one would expect that new channels would be at least one of the key new tactics.
by Anonymous (not verified)
To many of my readers, especially those from America, you may have difficulty understanding this blog.
Carl Icahn lets loose with Power Point assault on Lilly, Amylin & Byetta
There are some who see Carl Icahn as a savior for investors and others who see him as someone who defines the word greed and ruins companies.